| |
| |
|
| Insider
Information: |
Rubin Paul D |
| Relationship: |
Sr. VP Clinical Dev. &... |
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
326,601 |
|
|
Indirect Shares
|
13,422 |
|
|
| Direct
Value |
$7,854,754 |
|
|
|
Indirect Value
|
$322,799 |
|
|
| Total
Shares |
340,023 |
|
|
| Total
Value |
$8,177,553 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
XOMA Corporation |
XOMA |
Sr. VP Clinical Dev. &... |
2016-03-22 |
326,601 |
2016-03-22 |
13,422 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2015-07-10 |
4 |
AS |
$4.55 |
$131,985 |
D/D |
(29,000) |
122,345 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2015-03-23 |
4 |
AS |
$3.94 |
$128,879 |
D/D |
(32,742) |
119,467 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-03-18 |
4 |
AS |
$6.31 |
$111,423 |
D/D |
(17,649) |
90,719 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2015-07-10 |
4 |
OE |
$3.04 |
$88,160 |
D/D |
29,000 |
151,345 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2015-03-18 |
4 |
D |
$4.01 |
$82,356 |
D/D |
(20,535) |
152,209 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-08-18 |
4 |
AS |
$4.36 |
$71,752 |
D/D |
(16,449) |
72,021 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-06-16 |
4 |
AS |
$4.54 |
$52,595 |
D/D |
(11,580) |
72,021 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-01-21 |
4 |
AS |
$8.27 |
$49,608 |
D/D |
(6,000) |
3,228 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-09-04 |
4 |
AS |
$4.56 |
$45,640 |
D/D |
(10,000) |
72,021 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-02-18 |
4 |
AS |
$7.55 |
$45,272 |
D/D |
(6,000) |
3,228 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-08-15 |
4 |
AS |
$4.31 |
$44,341 |
D/D |
(10,299) |
88,470 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2013-08-14 |
4 |
S |
$3.86 |
$40,621 |
D/D |
(10,520) |
20,329 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-05-13 |
4 |
S |
$3.84 |
$38,404 |
D/D |
(10,000) |
80,719 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2013-12-18 |
4 |
AS |
$5.67 |
$33,992 |
D/D |
(6,000) |
3,534 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-09-04 |
4 |
OE |
$3.04 |
$30,400 |
D/D |
10,000 |
82,021 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2013-07-18 |
4 |
AS |
$4.71 |
$28,233 |
D/D |
(6,000) |
4,101 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2013-09-18 |
4 |
AS |
$4.53 |
$27,187 |
D/D |
(6,000) |
8,329 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2013-10-18 |
4/A |
AS |
$4.71 |
$24,725 |
D/D |
(5,254) |
3,534 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2013-03-19 |
4 |
S |
$3.29 |
$22,997 |
D/D |
(6,990) |
13,251 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2015-07-15 |
4 |
AS |
$4.60 |
$22,992 |
D/D |
(5,000) |
122,345 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-09-15 |
4 |
AS |
$4.59 |
$22,939 |
D/D |
(5,000) |
72,021 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-10-28 |
4 |
AS |
$4.57 |
$22,829 |
D/D |
(5,000) |
72,021 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-11-20 |
4 |
AS |
$4.55 |
$22,750 |
D/D |
(5,000) |
72,021 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2013-08-19 |
4 |
AS |
$3.74 |
$22,419 |
D/D |
(6,000) |
14,329 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2013-11-27 |
4 |
AS |
$4.54 |
$21,320 |
D/D |
(4,696) |
3,534 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
